The trademark application IMVANEX was filed by Bavarian Nordic A/S, a corporation established under the laws of the Kingdom of Denmark (the "Applicant"). The application was published for oppositions on March 26, 2023, and it was registered by office on July 3, 2023 without any oppositions.
The application was filed in Danish (English was selected as the second language).
Goods And Services
The mark was filed in class 5 with Virus-based pharmaceutical preparations for human medical and veterinary purposes, namely, vaccines for the treatment and prevention of diseases caused by infectious agents, preparations for the treatment and prevention of smallpox, product for the treatment of and/or prevention of tumor diseases, vaccines for stimulating the immune system, preparations for enabling the transient expression of therapeutic gene products, vaccines and adjuvants for use with vaccines.